Comments
The Committee of Directors of Natco Pharma Limited has approved a move to raise about Rs 915 crore through qualified institutional placement.
The committee, which met on Friday, approved the issue of one crore equity shares of face value of Rs 2 each to eligible qualified institutional buyers at the issue price of Rs 915 per equity share, including a premium of Rs 913, aggregating to Rs 915 crore, the pharma company informed BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.